전남대학교 중앙도서관

  • 중앙도서관
  • 여수캠퍼스도서관
  • 법학도서관
  • 치의학도서관
  • 의학도서관

링크메뉴

  • 화면키우기 화면줄이기 화면크기 원래대로
  • S
  • HOME
  • 로그인
  • 전남대
  • ENG
  • CHN

주메뉴

전체메뉴

전자자료 상세검색

전자자료 상세검색

통합검색
상세검색
검색어 [키워드: "O'Donnell DM"]
총 61건 
※ 페이지 이동 시, 중복 레코드가 제거되므로 초기 검색결과 수와 차이가 있을 수 있습니다.
3/7 페이지 RSS 엑셀파일 출력
검색결과수정
  • 검색범위확장
    • Full Text내 키워드 확장
    • 관련 주제어 확장

    재검색

  • 검색결과제한
    • 원문(Full Text)
    • Peer-Reviewed 학술지
    • 발행년 -

    재검색

  • 자료유형
    • Academic Journals (60)
    • Magazines (1)

    재검색

  • 주제
    • ovarian neoplasms (9)
    • neoplasms (7)
    • exercise (4)

    더보기

    재검색

  • 간행물
    • ajr american journal of roentgenology (4)
    • hydrobiologia (3)
    • lancet oncology (3)

    더보기

    재검색

  • 출판사
    • american roentgen ray society (4)
    • american society of clinical oncology (3)
    • elsevier (3)

    더보기

    재검색

  • 언어
    • english (61)

    재검색

  • 수록데이터베이스
    • MEDLINE (46)
    • Science Citation Index Expanded (10)
    • CINAHL Plus with Full Text (2)

    더보기

    재검색

  • PQDTSearch
  • CAJSearch
  • RISSSearch
  • PsycINFOSearch

 

21
The systemic treatment of recurrent ovarian cancer revisited. 미리보기

학술저널

issue
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2021 Jun; Vol. 32 (6), pp. 710-725. Date of Electronic Publication: 2021 Mar 03.
Author
Baert T; Department of Gynecology and Gynecological Oncology, Kliniken Essen-Mitte, Essen, Germany; Department of Oncology, KU Leuven, Leuven, Belgium. Electronic address: thais.baert@gmail.com.
Ferrero A; Department of Clinical and Experimental Medicine, Division of Gynecology and Obstetrics, Mauriziano Hospital, Turin, Italy.
Sehouli J; Department of Gynecology with Center for Oncological Surgery, Charité-University hospital Berlin, Berlin, Germany.
O'Donnell DM; Department of Oncology, St. James's Hospital, Dublin, Ireland.
González-Martín A; Medical Oncology Department, Clínica Universidad de Navarra University Hospital, Madrid, Spain.
Joly F; Department of Oncology, Centre Francois Baclesse, Caen, France.
van der Velden J; Department of Medical Oncology, Academic Medical Center Amsterdam, Amsterdam, The Netherlands.
Blecharz P; Department of Gynecologic Oncology, Center of Oncology, M. Sklodowska-Curie Institute, Krakow, Poland.
Tan DSP; Department of Haematology-Oncology, National University Cancer Institute of Singapore, Singapore; Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Querleu D; Department of Surgical Oncology, Institut Bergonié, Bordeaux, France.
Colombo N; Department of Medicine and Surgery, European Institute of Oncology IRCCS, Milan, Italy; University of Milan-Bicocca, Milan, Italy.
du Bois A; Department of Gynecology and Gynecological Oncology, Kliniken Essen-Mitte, Essen, Germany.
Ledermann JA; Cancer Research UK and UCL Cancer Trials Centre, UCL Cancer Institute, London, UK.
DB Label
Database : MEDLINE
원문보기
Full Text (ScienceDirect O/A)  등재 - SCOPUS  조회 - Impact Factor (JCR)  등재 - Web of Science (SCIE) 
23
Prevalence of Insomnia in an Oncology Patient Population: An Irish Tertiary Referral Center Experience. 미리보기

학술저널

issue
Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2020 Dec 02; Vol. 18 (12), pp. 1623-1630. Date of Electronic Publication: 2020 Dec 02 (Print Publication: 2020).
Author
Harrold EC; 1Department of Medical Oncology, Mater Misericordiae University Hospital, Dublin, Ireland.
Idris AF; 2Department of Medical Oncology, St. James's Hospital, Dublin, Ireland.
Keegan NM; 3Department of Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
Corrigan L; 2Department of Medical Oncology, St. James's Hospital, Dublin, Ireland.
Teo MY; 3Department of Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
O'Donnell M; 4Trinity College Medical School, Dublin, Ireland; and.
Lim ST; 4Trinity College Medical School, Dublin, Ireland; and.
Duff E; 4Trinity College Medical School, Dublin, Ireland; and.
O'Donnell DM; 2Department of Medical Oncology, St. James's Hospital, Dublin, Ireland.
Kennedy MJ; 2Department of Medical Oncology, St. James's Hospital, Dublin, Ireland.
Sukor S; 2Department of Medical Oncology, St. James's Hospital, Dublin, Ireland.
Grant C; 2Department of Medical Oncology, St. James's Hospital, Dublin, Ireland.
Gallagher DG; 2Department of Medical Oncology, St. James's Hospital, Dublin, Ireland.
Collier S; 5Department of Psychological Oncology Medicine, St. James's University Hospital, Dublin, Ireland.
Kingston T; 5Department of Psychological Oncology Medicine, St. James's University Hospital, Dublin, Ireland.
O'Dwyer AM; 5Department of Psychological Oncology Medicine, St. James's University Hospital, Dublin, Ireland.
Cuffe S; 2Department of Medical Oncology, St. James's Hospital, Dublin, Ireland.
DB Label
Database : MEDLINE
원문보기
등재 - SCOPUS  조회 - Impact Factor (JCR)  등재 - Web of Science (SCIE) 
24
Understanding and Attitudes toward Cancer Clinical Trials among Patients with a Cancer Diagnosis: National Study through Cancer Trials Ireland. 미리보기

학술저널

issue
Cancers [Cancers (Basel)] 2020 Jul 16; Vol. 12 (7). Date of Electronic Publication: 2020 Jul 16.
Author
Kearns C; UCD Conway Institute Dublin, D04V1W8 Dublin, Ireland.; Cancer Trials Ireland, Innovation House, Old Finglas Road, Glasnevin, D11KXN4 Dublin, Ireland.
Feighery R; Cancer Trials Ireland, Innovation House, Old Finglas Road, Glasnevin, D11KXN4 Dublin, Ireland.
Mc Caffrey J; UCD School of Medicine, Mater Misericordiae University Hospital Dublin, D07AX57 Dublin, Ireland.; Cancer Trials Ireland, Innovation House, Old Finglas Road, Glasnevin, D11KXN4 Dublin, Ireland.
Higgins M; UCD School of Medicine, Mater Misericordiae University Hospital Dublin, D07AX57 Dublin, Ireland.; Cancer Trials Ireland, Innovation House, Old Finglas Road, Glasnevin, D11KXN4 Dublin, Ireland.
Smith M; UCD School of Medicine, Mater Misericordiae University Hospital Dublin, D07AX57 Dublin, Ireland.; Cancer Trials Ireland, Innovation House, Old Finglas Road, Glasnevin, D11KXN4 Dublin, Ireland.
Murphy V; Cancer Trials Ireland, Innovation House, Old Finglas Road, Glasnevin, D11KXN4 Dublin, Ireland.
O'Reilly S; Cancer Trials Ireland, Innovation House, Old Finglas Road, Glasnevin, D11KXN4 Dublin, Ireland.; Cork University Hospital, T12DFK4 Cork, Ireland.
Horgan AM; Cancer Trials Ireland, Innovation House, Old Finglas Road, Glasnevin, D11KXN4 Dublin, Ireland.; University Hospital Waterford, X91ER8E Waterford, Ireland.
Walshe J; Cancer Trials Ireland, Innovation House, Old Finglas Road, Glasnevin, D11KXN4 Dublin, Ireland.; St. Vincent University Hospital, D04YN63 Dublin, Ireland.
McDermott R; Cancer Trials Ireland, Innovation House, Old Finglas Road, Glasnevin, D11KXN4 Dublin, Ireland.; Adelaide & Meath Hospital Incorporating the National Children's Hospital (AMNCH), D24KNE0 Dublin, Ireland.
Morris PG; Cancer Trials Ireland, Innovation House, Old Finglas Road, Glasnevin, D11KXN4 Dublin, Ireland.; Beaumont Hospital, D09A0KH Dublin, Ireland.
Keane M; Cancer Trials Ireland, Innovation House, Old Finglas Road, Glasnevin, D11KXN4 Dublin, Ireland.; Galway University Hospital, SW4794 Galway, Ireland.
Martin M; Cancer Trials Ireland, Innovation House, Old Finglas Road, Glasnevin, D11KXN4 Dublin, Ireland.; Sligo General Hospital, F91H684 Sligo, Ireland.
Murphy C; Cancer Trials Ireland, Innovation House, Old Finglas Road, Glasnevin, D11KXN4 Dublin, Ireland.; Bon Secours Hospital, T12DV56 Cork, Ireland.
Duffy K; Cancer Trials Ireland, Innovation House, Old Finglas Road, Glasnevin, D11KXN4 Dublin, Ireland.; Letterkenny General Hospital, F92FC82 Donegal, Ireland.
Mihai A; Cancer Trials Ireland, Innovation House, Old Finglas Road, Glasnevin, D11KXN4 Dublin, Ireland.; Beacon Hospital, D18AK68 Dublin, Ireland.
Armstrong J; Cancer Trials Ireland, Innovation House, Old Finglas Road, Glasnevin, D11KXN4 Dublin, Ireland.; St. Luke's Radiation Oncology Network, St Luke's Hospital, Rathgar, D06HH36 Dublin, Ireland.
O'Donnell DM; Cancer Trials Ireland, Innovation House, Old Finglas Road, Glasnevin, D11KXN4 Dublin, Ireland.; St. James's Hospital, D08W9RT Dublin, Ireland.
Gallagher WM; UCD Conway Institute Dublin, D04V1W8 Dublin, Ireland.; Cancer Trials Ireland, Innovation House, Old Finglas Road, Glasnevin, D11KXN4 Dublin, Ireland.
Kelly CM; UCD School of Medicine, Mater Misericordiae University Hospital Dublin, D07AX57 Dublin, Ireland.; Cancer Trials Ireland, Innovation House, Old Finglas Road, Glasnevin, D11KXN4 Dublin, Ireland.
Kelly CM; UCD Conway Institute Dublin, D04V1W8 Dublin, Ireland.; UCD School of Medicine, Mater Misericordiae University Hospital Dublin, D07AX57 Dublin, Ireland.; Cancer Trials Ireland, Innovation House, Old Finglas Road, Glasnevin, D11KXN4 Dublin, Ireland.
DB Label
Database : MEDLINE
원문보기
Full Text Full Text (원문보기) PLinkFull Text (원문보기) Open Access (PubMed Central)  등재 - SCOPUS  조회 - Impact Factor (JCR)  등재 - Web of Science (SCIE) 
25
Weekly platinum-based chemotherapy versus 3-weekly platinum-based chemotherapy for newly diagnosed ovarian cancer (ICON8): quality-of-life results of a phase 3, randomised, controlled trial. 미리보기

학술저널

issue
The Lancet. Oncology [Lancet Oncol] 2020 Jul; Vol. 21 (7), pp. 969-977.
Author
Blagden SP; Department of Oncology, University of Oxford, Oxford, UK. Electronic address: sarah.blagden@oncology.ox.ac.uk.
Cook AD; Medical Research Council Clinical Trials Unit, Institute of Clinical Trials and Methodology, University College London, London, UK.
Poole C; Department of Oncology, University Hospital Coventry, Coventry, UK.
Howells L; Maggie Keswick Jencks Cancer Caring Centres Trust, London, UK.
McNeish IA; Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College London, London, UK.
Dean A; Oncology Department, St John of God Subiaco Hospital, Perth, WA, Australia.
Kim JW; Department of Obstetrics and Gynaecology, Seoul National University Hospital, Seoul, South Korea.
O'Donnell DM; Gynaecology Subgroup, Cancer Trials Ireland, Dublin, Ireland.
Hook J; St James's University Hospital, Leeds, UK.
James EC; Medical Research Council Clinical Trials Unit, Institute of Clinical Trials and Methodology, University College London, London, UK.
White IR; Medical Research Council Clinical Trials Unit, Institute of Clinical Trials and Methodology, University College London, London, UK.
Perren T; St James's University Hospital, Leeds, UK.
Lord R; Department of Oncology, Clatterbridge Cancer Centre, Birkenhead, UK.
Dark G; Department of Oncology, Newcastle University, Newcastle, UK.
Earl HM; NIHR Cambridge Biomedical Research Centre, Cambridge, UK.
Hall M; Department of Medical Oncology, Mount Vernon Cancer Centre, Northwood, UK.
Kaplan R; Medical Research Council Clinical Trials Unit, Institute of Clinical Trials and Methodology, University College London, London, UK.
Ledermann JA; UCL Cancer Centre Institute, University College London, London, UK; University College Hospital, London, UK.
Clamp AR; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK; University of Manchester, Manchester, UK.
DB Label
Database : MEDLINE
원문보기
Full Text (ScienceDirect)  Full Text (Clinical Key)  등재 - SCOPUS  조회 - Impact Factor (JCR)  등재 - Web of Science (SCIE) 
26
Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial. 미리보기

학술저널

issue
Lancet (London, England) [Lancet] 2019 Dec 07; Vol. 394 (10214), pp. 2084-2095. Date of Electronic Publication: 2019 Nov 29.
Author
Clamp AR; Department of Medical Oncology, The Christie National Health Service Foundation Trust, and University of Manchester, Manchester, UK.
James EC; Medical Research Council Clinical Trials Unit at University College London, Institute of Clinical Trials & Methodology, University College London, London, UK. Electronic address: e.james@ucl.ac.uk.
McNeish IA; Department of Surgery and Cancer, Imperial College London, London, UK.
Dean A; Oncology Department, St John of God Hospital, Subiaco, WA, Australia.
Kim JW; Department of Obstetrics and Gynaecology, Seoul National University, Seoul, Korea.
O'Donnell DM; Cancer Trials Ireland, Dublin, Ireland.
Hook J; St James' University Hospital, Leeds, UK.
Coyle C; Queen Alexandra Hospital, Portsmouth Hospitals National Health Service Trust, Portsmouth, UK.
Blagden S; Churchill Hospital, University of Oxford, Oxford, UK.
Brenton JD; Li Ka Shing Centre, Cancer Research UK Cambridge Institute, Cambridge, UK.
Naik R; Gynaecology Oncology Centre, Queen Elizabeth Hospital, Gateshead, UK.
Perren T; St James' University Hospital, Leeds, UK.
Sundar S; Institute of Cancer and Genomics, University of Birmingham, Birmingham, UK.
Cook AD; Medical Research Council Clinical Trials Unit at University College London, Institute of Clinical Trials & Methodology, University College London, London, UK.
Gopalakrishnan GS; Medical Research Council Clinical Trials Unit at University College London, Institute of Clinical Trials & Methodology, University College London, London, UK.
Gabra H; Department of Surgery and Cancer, Imperial College London, London, UK; Early Clinical Development, AstraZeneca, Cambridge, UK.
Lord R; Department of Oncology, Clatterbridge Cancer Centre, Wirral, UK.
Dark G; Northern Centre for Cancer Care, Freeman Hospital, Newcastle, UK.
Earl HM; Department of Medical Oncology, Addenbrooke's Hospital, Cambridge, UK.
Hall M; Department of Medical Oncology, Mount Vernon Cancer Centre, Northwood, UK.
Banerjee S; Gynaecological Unit, The Royal Marsden National Health Service Foundation Trust and Institute of Cancer Research, London, UK.
Glasspool RM; Beatson West of Scotland Cancer Centre, Glasgow, UK.
Jones R; Velindre Cancer Centre, Wales, UK.
Williams S; Birmingham City Hospital, Birmingham, UK.
Swart AM; Norwich Medical School, University of East Anglia, Norwich, UK.
Stenning S; Medical Research Council Clinical Trials Unit at University College London, Institute of Clinical Trials & Methodology, University College London, London, UK.
Parmar M; Medical Research Council Clinical Trials Unit at University College London, Institute of Clinical Trials & Methodology, University College London, London, UK.
Kaplan R; Medical Research Council Clinical Trials Unit at University College London, Institute of Clinical Trials & Methodology, University College London, London, UK.
Ledermann JA; University College London Cancer Institute, and University College London Hospitals, London, UK.
DB Label
Database : MEDLINE
원문보기
Full Text (ScienceDirect)  Full Text (Clinical Key)  등재 - SCOPUS  조회 - Impact Factor (JCR)  등재 - Web of Science (SCIE) 
28
When RON MET TAM in Mesothelioma: All Druggable for One, and One Drug for All? 미리보기

학술저널

issue
Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2019 Feb 26; Vol. 10, pp. 89. Date of Electronic Publication: 2019 Feb 26 (Print Publication: 2019).
Author
Baird AM; Thoracic Oncology Research Group, Labmed Directorate, St. James's Hospital, Dublin, Ireland.; Cancer and Ageing Research Program, Queensland University of Technology, Brisbane, QLD, Australia.
Easty D; Thoracic Oncology Research Group, Labmed Directorate, St. James's Hospital, Dublin, Ireland.
Jarzabek M; Department of Physiology and Medical Physics and Centre for Systems Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland.
Shiels L; Department of Physiology and Medical Physics and Centre for Systems Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland.
Soltermann A; Department of Clinical Pathology, University Hospital Zurich, Zurich, Switzerland.
Klebe S; Department of Anatomical Pathology, Flinders University of South Australia, Bedford Park, SA, Australia.
Raeppel S; ChemRF Laboratories, Montréal, QC, Canada.
MacDonagh L; Thoracic Oncology Research Group, Labmed Directorate, St. James's Hospital, Dublin, Ireland.
Wu C; Department of Clinical Pathology, University Hospital Zurich, Zurich, Switzerland.
Griggs K; Department of Anatomical Pathology, Flinders University of South Australia, Bedford Park, SA, Australia.
Kirschner MB; Asbestos Diseases Research Institute, Sydney, NSW, Australia.; Sydney Medical School, University of Sydney, NSW, Australia.
Stanfill B; The Commonwealth Scientific and Industrial Research Organization, Brisbane, QLD, Australia.
Nonaka D; Department of Histopathology, The Christie NHS Foundation Trust, Manchester, United Kingdom.; Department of Cardiothoracic Surgery, New York University (NYU) Langone Medical Center, New York, NY, United States.
Goparaju CM; Department of Cardiothoracic Surgery, New York University (NYU) Langone Medical Center, New York, NY, United States.
Murer B; Department of Clinical Pathology, Ospedale dell'Angelo, Venice, Italy.
Fennell DA; MRC Toxicology Unit, University of Leicester and Leicester University Hospitals, Leicester, United Kingdom.
O'Donnell DM; HOPE Directorate, St James's Hospital, Dublin, Ireland.
Barr MP; Thoracic Oncology Research Group, Labmed Directorate, St. James's Hospital, Dublin, Ireland.
Mutti L; Center for Biotechnology, Sbarro Institute for Cancer Research and Molecular Medicine, College of Science and Technology, Temple University, Philadelphia, PA, United States.
Reid G; Asbestos Diseases Research Institute, Sydney, NSW, Australia.; Sydney Medical School, University of Sydney, NSW, Australia.
Finn S; Department of Histopathology and Morbid Anatomy, Trinity College Dublin, Dublin, Ireland.
Cuffe S; HOPE Directorate, St James's Hospital, Dublin, Ireland.
Pass HI; Department of Cardiothoracic Surgery, New York University (NYU) Langone Medical Center, New York, NY, United States.
Opitz I; Department of Thoracic Surgery, University Hospital Zurich, Zurich, Switzerland.
Byrne AT; Department of Physiology and Medical Physics and Centre for Systems Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland.
O'Byrne KJ; Thoracic Oncology Research Group, Labmed Directorate, St. James's Hospital, Dublin, Ireland.; Cancer and Ageing Research Program, Queensland University of Technology, Brisbane, QLD, Australia.; HOPE Directorate, St James's Hospital, Dublin, Ireland.; Division of Cancer Services, Princess Alexandra Hospital, Brisbane, QLD, Australia.
Gray SG; Thoracic Oncology Research Group, Labmed Directorate, St. James's Hospital, Dublin, Ireland.; Department of Clinical Medicine, Trinity College Dublin, Dublin, Ireland.
DB Label
Database : MEDLINE
원문보기
Open Access (PubMed Central)  등재 - SCOPUS  조회 - Impact Factor (JCR)  등재 - Web of Science (SCIE) 
30
The ExPeCT (Examining Exercise, Prostate Cancer and Circulating Tumour Cells) trial: study protocol for a randomised controlled trial. 미리보기

학술저널

issue
Trials [Trials] 2017 Oct 04; Vol. 18 (1), pp. 456. Date of Electronic Publication: 2017 Oct 04.
Author
Sheill G; Discipline of Physiotherapy, School of Medicine, Trinity College Dublin, Dublin, Ireland. sheillg@tcd.ie.
Brady L; Department of Histopathology and Morbid Anatomy, Trinity Translational Medicine Institute, Dublin, Ireland.
Guinan E; School of Medicine, Trinity College Dublin, Dublin, Ireland.
Hayes B; Department of Histopathology and Morbid Anatomy, Trinity Translational Medicine Institute, Dublin, Ireland.; Department of Histopathology, Cork University Hospital, Wilton, Cork, Ireland.
Casey O; Cancer Trials Ireland, Dublin, Ireland.
Greene J; Department of Histopathology and Morbid Anatomy, Trinity Translational Medicine Institute, Dublin, Ireland.
Vlajnic T; Institute of Pathology, University Hospital Basel, Basel, Switzerland.
Cahill F; King's College London, School of Cancer and Pharmaceutical Sciences, Translational Oncology & Urology Research (TOUR) , London, UK.
Van Hemelrijck M; King's College London, School of Cancer and Pharmaceutical Sciences, Translational Oncology & Urology Research (TOUR) , London, UK.
Peat N; Guy's and St Thomas' NHS Foundation Trust, London, UK.
Rudman S; King's College London, School of Cancer and Pharmaceutical Sciences, Translational Oncology & Urology Research (TOUR) , London, UK.; Guy's and St Thomas' NHS Foundation Trust, London, UK.
Hussey J; Discipline of Physiotherapy, School of Medicine, Trinity College Dublin, Dublin, Ireland.
Cunningham M; Cancer Trials Ireland, Dublin, Ireland.; Department of Radiation Oncology, St Luke's Hospital, Dublin, Ireland.
Grogan L; Cancer Trials Ireland, Dublin, Ireland.; Department of Oncology, Beaumont Hospital, Dublin, Ireland.
Lynch T; Department of Urology, St James's Hospital, Dublin, Ireland.
Manecksha RP; Department of Urology, St James's Hospital, Dublin, Ireland.
McCaffrey J; Cancer Trials Ireland, Dublin, Ireland.; Department of Oncology, Mater Misericordiae, Dublin, Ireland.
Mucci L; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, USA.
Sheils O; Department of Histopathology and Morbid Anatomy, Trinity Translational Medicine Institute, Dublin, Ireland.
O'Leary J; Department of Histopathology and Morbid Anatomy, Trinity Translational Medicine Institute, Dublin, Ireland.; Department of Histopathology, St James's Hospital, Dublin, Ireland.
O'Donnell DM; Cancer Trials Ireland, Dublin, Ireland.; HOPE Directorate, St James's Hospital, Dublin, Ireland.
McDermott R; Cancer Trials Ireland, Dublin, Ireland.; Department of Oncology, Adelaide and Meath Hospital incorporating the National Children's Hospital, Dublin, Ireland.
Finn S; Department of Histopathology and Morbid Anatomy, Trinity Translational Medicine Institute, Dublin, Ireland.; Cancer Trials Ireland, Dublin, Ireland.; Department of Histopathology, St James's Hospital, Dublin, Ireland.
DB Label
Database : MEDLINE
원문보기
Full Text Full Text (원문보기) Open Access (PubMed Central)  Open Access (BioMed Central)  OA (Springer)  등재 - SCOPUS  조회 - Impact Factor (JCR)  등재 - Web of Science (SCIE) 
1 2 3 4 5  
바구니보기

QUICK LINK

  • 희망도서신청
  • 대출/연장조회
  • 서가부재도서
  • 이용교육

마이메뉴추가

QRCode
  • 개인정보호정책
  • 이메일무단수집거부
  • 도서관이용문의

    • 도서관자치위원회  원격제어  Instagram  facebook  w  kakao 플친
500-757 광주광역시 북구 용봉로 77 TEL 062)530-3571~2(대출반납실) FAX 062)530-3529
Copyright@2013 CHONNAM NATIONAL UNIVERSITY LIBRARY, All Rights Reserved.
  • 72525
  • 129670887